Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.012 AUD Market Closed
Market Cap: 24.6m AUD
Have any thoughts about
Bioxyne Ltd?
Write Note

Intrinsic Value

BXN doesn't have a meaningful market cap.

The intrinsic value of one BXN stock under the Base Case scenario is 0.009 AUD. Compared to the current market price of 0.012 AUD, Bioxyne Ltd is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BXN Intrinsic Value
0.009 AUD
Overvaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioxyne Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BXN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BXN?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Bioxyne Ltd

Provide an overview of the primary business activities
of Bioxyne Ltd.

What unique competitive advantages
does Bioxyne Ltd hold over its rivals?

What risks and challenges
does Bioxyne Ltd face in the near future?

Has there been any significant insider trading activity
in Bioxyne Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioxyne Ltd.

Provide P/S
for Bioxyne Ltd.

Provide P/E
for Bioxyne Ltd.

Provide P/OCF
for Bioxyne Ltd.

Provide P/FCFE
for Bioxyne Ltd.

Provide P/B
for Bioxyne Ltd.

Provide EV/S
for Bioxyne Ltd.

Provide EV/GP
for Bioxyne Ltd.

Provide EV/EBITDA
for Bioxyne Ltd.

Provide EV/EBIT
for Bioxyne Ltd.

Provide EV/OCF
for Bioxyne Ltd.

Provide EV/FCFF
for Bioxyne Ltd.

Provide EV/IC
for Bioxyne Ltd.

Compare the intrinsic valuations
of Bioxyne Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioxyne Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioxyne Ltd compared to its peers.

Compare the P/E ratios
of Bioxyne Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioxyne Ltd with its peers.

Analyze the financial leverage
of Bioxyne Ltd compared to its main competitors.

Show all profitability ratios
for Bioxyne Ltd.

Provide ROE
for Bioxyne Ltd.

Provide ROA
for Bioxyne Ltd.

Provide ROIC
for Bioxyne Ltd.

Provide ROCE
for Bioxyne Ltd.

Provide Gross Margin
for Bioxyne Ltd.

Provide Operating Margin
for Bioxyne Ltd.

Provide Net Margin
for Bioxyne Ltd.

Provide FCF Margin
for Bioxyne Ltd.

Show all solvency ratios
for Bioxyne Ltd.

Provide D/E Ratio
for Bioxyne Ltd.

Provide D/A Ratio
for Bioxyne Ltd.

Provide Interest Coverage Ratio
for Bioxyne Ltd.

Provide Altman Z-Score Ratio
for Bioxyne Ltd.

Provide Quick Ratio
for Bioxyne Ltd.

Provide Current Ratio
for Bioxyne Ltd.

Provide Cash Ratio
for Bioxyne Ltd.

What is the historical Revenue growth
over the last 5 years for Bioxyne Ltd?

What is the historical Net Income growth
over the last 5 years for Bioxyne Ltd?

What is the current Free Cash Flow
of Bioxyne Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioxyne Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioxyne Ltd

Current Assets 5.6m
Cash & Short-Term Investments 1m
Receivables 1.5m
Other Current Assets 3m
Non-Current Assets 1.1m
PP&E 824.1k
Intangibles 288.5k
Other Non-Current Assets -10
Current Liabilities 2.9m
Accounts Payable 2.7m
Other Current Liabilities 252.5k
Non-Current Liabilities 184.1k
Other Non-Current Liabilities 184.1k
Efficiency

Earnings Waterfall
Bioxyne Ltd

Revenue
9.3m AUD
Cost of Revenue
-5.9m AUD
Gross Profit
3.4m AUD
Operating Expenses
-5.1m AUD
Operating Income
-1.7m AUD
Other Expenses
-11.1m AUD
Net Income
-12.8m AUD

Free Cash Flow Analysis
Bioxyne Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BXN Profitability Score
Profitability Due Diligence

Bioxyne Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
29/100
Profitability
Score

Bioxyne Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

BXN Solvency Score
Solvency Due Diligence

Bioxyne Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
63/100
Solvency
Score

Bioxyne Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BXN Price Targets Summary
Bioxyne Ltd

There are no price targets for BXN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BXN?

Click here to dive deeper.

Dividends

Bioxyne Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for BXN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BXN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Bioxyne Ltd Logo
Bioxyne Ltd

Country

Australia

Industry

Consumer products

Market Cap

24.6m AUD

Dividend Yield

0%

Description

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

Contact

NEW SOUTH WALES
Sydney
Se 506 L 5, 50 Clarence Street
+61290788180.0
www.bioxyne.com

IPO

2000-12-14

Employees

-

Officers

CEO, MD & Executive Director
Mr. Samuel Watson
CFO & Company Secretary
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD
COO & Executive Director
Mr. Jason Hine
Managing Director of BLS Japan
Naotaka Tei
Financial Controller & Assistant Company Secretary
Ms. Rachel Qian

See Also

Discover More
What is the Intrinsic Value of one BXN stock?

The intrinsic value of one BXN stock under the Base Case scenario is 0.009 AUD.

Is BXN stock undervalued or overvalued?

Compared to the current market price of 0.012 AUD, Bioxyne Ltd is Overvalued by 29%.

Back to Top